Desensitization of Human Mast Cells: Mechanisms and Potential Utility for Preventing Anaphylaxis



Status:Archived
Conditions:Hospital
Therapuetic Areas:Other
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:January 2009
End Date:January 2012

Use our guide to learn which trials are right for you!

Open-Label, Single-Center Study of Whether Oral Penicillin Desensitization of Healthy Sensitive Subjects Results in Allergen Cross-Desensitization of Mast Cells by Skin Testing and Desensitization of Peripheral Blood Basophils.


This is an open-label, single-center study of whether oral penicillin desensitization of
healthy sensitive subjects results in allergen cross-desensitization of mast cells by skin
testing and desensitization of peripheral blood basophils. The primary endpoint(s) will be
PC3 prick skin test values to penicillin, aeroallergen(s) and codeine. Secondary endpoints
will be levels of Syk in purified basophils determined by flow cytometry (mean fluorescence
intensity) and basophil degranulation (% tryptase release) to anti-FcåRI and to calcium
ionophore.



We found this trial at
1
site
1250 E. Marshall St.
Richmond, Virginia 23298
(804) 828-9000
Virginia Commonwealth University Medical Center The Virginia Commonwealth University Health System is an urban, comprehensive...
?
mi
from
Richmond, VA
Click here to add this to my saved trials